关注
Bartolome Celli
Bartolome Celli
未知所在单位机构
在 copdnet.org 的电子邮件经过验证
标题
引用次数
年份
¿ Debemos tener en cuenta la capacidad inspiratoria?
C Casanova Macario, BR Celli
Arch. bronconeumol.(Ed. impr.), 245-247, 2007
112007
¿ Es realmente la enfermedad pulmonar obstructiva crónica una enfermedad progresiva?
JP de Torres, BR Celli
Arch. bronconeumol.(Ed. impr.), 362-363, 2017
42017
'rapid'Fev1 Decline In Healthy Young Adults Predicts Albuminuria Later In Life
S Bhatia, A Sood, C Qualls, T Crowell, B Thyagarajan, A Arynchyn, ...
D39. CONNECTING THE DOTS: DRAWING LINES BETWEEN COPD AND COMORBID CONDITIONS …, 2014
2014
" Increased gastro-oesophageal reflux disease in patients with severe COPD." C. Casanova, JS Baudet, M. del Valle Velasco, JM Martin, A. Aguirre-Jaime, J. Pablo de Torres, BR …
C Casanova, JS Baudet, MD Velasco, JM Martin, A Aguirre-Jaime, ...
EUROPEAN RESPIRATORY JOURNAL 24 (6), 1074-1074, 2004
12004
" Treadmill endurance during 2 years" treatment with tiotropium in patients with COPD
CB Cooper, B Celli, RA Wise, JR Jardim, D Legg, J Guo, S Kesten
American Journal of Respiratory and Critical Care Medicine 183 (Meeting …, 2011
3*2011
800 ILIOFEMORAL ARTERIOVENOUS FISTULA DECREASES BLOOD PRESSURE IN SEVERE COPD PATIENTS WITH HYPERTENSION
S Brouwers, D Schoors, A Dupont, E Dolan, B Celli, C Cooper, ...
Journal of Hypertension 30, e232, 2012
52012
A 15-Year-Old with Sepsis and Cavitary Lung Lesions
I Kogan, L Wolf, BR Celli
Journal of Intensive Care Medicine 16 (6), 290-293, 2001
2001
A 24-week randomized, double-blind, placebo-controlled study of the efficacy and safety of once-daily umeclidinium/vilanterol 125/25 mcg in COPD
BR Celli, G Crater, S Kilbride, R Mehta, M Tabberer, CJ Kalberg, ...
B23. PHARMACOLOGICAL TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: NEW …, 2013
92013
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
DP Tashkin, B Celli, S Senn, D Burkhart, S Kesten, S Menjoge, ...
New England Journal of Medicine 359 (15), 1543-1554, 2008
29602008
A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial)
D Tashkin, B Celli, S Senn, D Burkhart, S Kesten, S Menjoge, M Decramer
Revista portuguesa de pneumologia 15 (1), 137-140, 2009
152009
A 62-year-old woman with chronic obstructive pulmonary disease
BR Celli
JAMA 290 (20), 2721-2729, 2003
42003
A better way to assess bronchoreversibility: response
NA Hanania, BR Celli, JF Donohue, UJ Martin
Chest 141 (4), 1118-1119, 2012
12012
A Chronic Obstructive Pulmonary Disease-Genome-Wide Association Analysis of Blood Biomarkers in Chronic Obstructive Pulmonary Disease
DK Kim, MH Cho, CP Hersh, DA Lomas, BE Miller, X Kong, P Bakke, ...
American Journal of Respiratory and CriticalCare Medicine 186 (12), 1238, 2012
2012
A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease
RS Castaldo, BR Celli, F Gomez, N LaVallee, J Souhrada, JP Hanrahan
Clinical therapeutics 25 (2), 542-557, 2003
382003
A controlled trial of intermittent positive pressure breathing, incentive spirometry, and deep breathing exercises in preventing pulmonary complications after abdominal surgery
BR Celli, KS Rodriguez, GL Snider
American Review of Respiratory Disease 130 (1), 12-15, 1984
4901984
A Delphi consensus document on the use of single-inhaler fixed-dose triple therapies in COPD patients
JL López-Campos, B Alcázar Navarrete, JA Riesco Miranda, BG Cosío, ...
International Journal of Chronic Obstructive Pulmonary Disease, 1801-1811, 2020
22020
A disintegrin and metalloproteinase domain-8: a novel protective proteinase in chronic obstructive pulmonary disease
F Polverino, J Rojas-Quintero, X Wang, H Petersen, L Zhang, X Gai, ...
American journal of respiratory and critical care medicine 198 (10), 1254-1267, 2018
302018
A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease
J Menche, A Sharma, MH Cho, RJ Mayer, SI Rennard, B Celli, BE Miller, ...
BMC Systems Biology 8 (2), 1-13, 2014
222014
A Dose-Ranging Study (TERRANOVA) of Benralizumab for Moderate to Severe Chronic Obstructive Pulmonary Disease
BR Celli, GJ Criner, D Singh, M Bafadhel, V Backer, A Ramirez-Venegas, ...
B15. IMMUNOTHERAPY FOR LUNG DISEASE, A2625-A2625, 2019
12019
A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease
M Hardin, MH Cho, ML McDonald, E Wan, DA Lomas, HO Coxson, ...
The pharmacogenomics journal 16 (4), 326-335, 2016
332016
系统目前无法执行此操作,请稍后再试。
文章 1–20